A Promising New Avenue for Alzheimer’s Treatment: Experimental Molecule Reprograms Brain’s Immune Cells to Combat Disease
Researchers in Spain and Switzerland have identified an experimental molecule that may help restore the brain’s natural defenses against Alzheimer’s disease. The compound, known as OLE, appears to "reprogram" microglia,…
A Promising Experimental Compound Targets a Novel Pathway in Alzheimer’s Disease Progression
A groundbreaking experimental compound, developed through nearly two decades of dedicated research at ETH Zurich, is showing significant promise in offering a novel therapeutic avenue for slowing the relentless progression…
UK Medicines Regulator Launches Major Investigation into Clinics Making Unsubstantiated Claims for Experimental Peptide Therapies
The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a sweeping investigation into numerous UK clinics, probing whether they are in breach of the law by promoting experimental, unregulated…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple








